Events

- OCT 09 2019
10/6/2019: Velocity, Columbia’s Ride to End Cancer
Oncoceutics COO Lee Schalop gets ready to ride in support of the Brain Power team led by Andrew Lassman, MD, principal investigator of the company’s "ONC201 in Adults With Recurrent H3 K27M-mutant Glioma” study as part of 2019 Velocity, Columbia’s Ride to End Cancer.
Read >
- JUN 04 2019
Lee Schalop, COO of Oncoceutics to present at Jefferies Healthcare Conference on June 7 at 10:00am
Please find more details here.

Read >

- JUN 03 2019
Dr. Josh Allen to present at 6th Annual Brain Tumor Biotech Summit 2019 in New York, June 7th
Please find all details here.

Read >
- MAR 21 2019
Abstracts to be Presented at AACR 2019
Oncoceutics, Inc. and its commercial and academic collaborators will be presenting multiple abstracts at the 2019 annual meeting of the American Association for Cancer Research in Atlanta, Georgia, on March 29th to April 3rd. These abstracts will highlight ONC201’s unique mechanism of action, various single agent and combination data, and characterization of other imipridones, including

Read >

10/6/2019: Velocity, Columbia’s Ride to End Cancer